COPD: Interventions for smoking cessation and improved ventilatory function

Geriatrics

Volumn 55, Issue 12, 2000, Pages 30-39

  Petty, T L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CYTOKINE; OXIDIZING AGENT; PROTEINASE;

AGED; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE EXACERBATION; EMPHYSEMA; HUMAN; INFLAMMATION; PATHOGENESIS; RESPIRATORY FUNCTION; REVIEW; SMOKING CESSATION; SPIROMETRY;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRONCHODILATOR AGENTS; BUPROPION; DISEASE PROGRESSION; HUMANS; LUNG DISEASES, OBSTRUCTIVE; SMOKING CESSATION; SPIROMETRY;

EID: 0033639193     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Obstructive lung disease and low lung function in adults in the United States
2. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease
3. Novel approaches and targets for treatment of chronic obstructive pulmonary disease
4. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease
5. The 'horse-racing effect' and predicting decline in forced expiratory volume in one second from screening spirometry
6. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease
7. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease
8. Exercise rehabilitation and chronic obstructive pulmonary disease stage
9. 1. The Lung Health Study
10. The relevance in adults of air-flow obstruction, but not mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation
11. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
12. Effect of buspirone on withdrawal symptoms associated with smoking cessation
13. COPD: A disease of reversible air-flow obstruction
14. Management of chronic obstructive pulmonary diseases
15. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials
16. 1. The Lung Health Study
17. Efficacy of salmeterol xinafoate in the treatment of COPD
18. A comparison of the effect of ipratropium and albuterol in the treatment of chronic airway disease
19. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action
20. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial
21. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease
22. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease
23. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: A meta analysis
24. Aerosolized beclomethasone in chronic bronchitis: Improved pulmonary function and diminished airway inflammation
25. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
26. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease
27. Are inhaled glucocorticosteroids effective in chronic obstructive pulmonary disease?
28. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
29. Home oxygen - A revolution in the care of advanced COPD
30. Ambulatory oxygen. The standard of care
31. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. A clinical trial
32. Oxygen, exercise, and survival in advanced COPD. The Nocturnal Oxygen Therapy Trial revisited
33. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease